▶ 調査レポート

ニューカッスル病ワクチンの世界市場レポート2020

• 英文タイトル:Global Newcastle Disease Vaccine Sales Market Report 2020

QYResearchが調査・発行した産業分析レポートです。ニューカッスル病ワクチンの世界市場レポート2020 / Global Newcastle Disease Vaccine Sales Market Report 2020 / 20QY06-02633資料のイメージです。• レポートコード:20QY06-02633
• 出版社/出版日:QYResearch / 2020年6月1日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、145ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医薬品・医療
• 販売価格(消費税別)
  Single User¥592,000 (USD4,000)▷ お問い合わせ
  Multi User¥888,000 (USD6,000)▷ お問い合わせ
  Enterprise License¥1,184,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社の当調査資料では、ニューカッスル病ワクチンのグローバル市場について種類別(生ワクチン、殺菌ワクチン)、用途別(鶏肉、鴨肉、ガチョウ、その他)、地域別(北米、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。

・ニューカッスル病ワクチン市場の概要
・世界の主要地域別ニューカッスル病ワクチン市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界のニューカッスル病ワクチン市場規模2015-2026:種類別(生ワクチン、殺菌ワクチン)
・世界のニューカッスル病ワクチン市場規模2015-2026:用途別(鶏肉、鴨肉、ガチョウ、その他)
・ニューカッスル病ワクチンの北米市場規模2015-2020
・ニューカッスル病ワクチンのヨーロッパ市場規模2015-2020
・ニューカッスル病ワクチンの中国市場規模2015-2020
・ニューカッスル病ワクチンの日本市場規模2015-2020
・ニューカッスル病ワクチンの東南アジア市場規模2015-2020
・ニューカッスル病ワクチンのインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
(Merial、CEVA、QYH Biotech、Ringpu Biology、Yebio、Harbin Veterinary Research Institute、Merck Animal Health、DHN、Zoetis、ChengDu Tecbond、Elanco (Lohmann)、FATRO、CAVAC、Vaksindo)
・ニューカッスル病ワクチンの製造コスト分析
・販売チャネル、流通業者、顧客
・ニューカッスル病ワクチンの市場動向・機会・課題
・調査の結論

Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans.
Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines suitable for use in commercial chickens.
The classification of Newcastle Disease Vaccine includes Live Vaccines and Killed Vaccines. The proportion of Killed Vaccines in 2016 is about 77.1%, These vaccines are made with virus that is alive and able to infect cells. Strains of virus of low or moderate virulence are used. They mimic natural infection and induce all three immune responses. And the proportion of Live Vaccines in 2016 is about 22.9%.
Newcastle Disease Vaccine is application in Chicken, Duck & Goose and others. The most of Newcastle Disease Vaccine is used in Chicken, and the market share in 2016 is about 87.5%.
Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans. Newcastle disease can causes devastating losses in both commercial and village chickens. So Newcastle Disease Vaccine is necessary for farms with Chicken, Duck & Goose, etc.
Market competition is intense. Merial, CEVA, QYH Biotech, Ringpu Biology, etc. are the leader of this industry. With the development of society and the changing of consumer demand, the Newcastle Disease Vaccine industry will be more and more popular in the future.

Market Analysis and Insights: Global Newcastle Disease Vaccine Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Newcastle Disease Vaccine market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Newcastle Disease Vaccine industry.
Based on our recent survey, we have several different scenarios about the Newcastle Disease Vaccine YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 296.7 million in 2019. The market size of Newcastle Disease Vaccine will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.

Global Newcastle Disease Vaccine Scope and Market Size
The global Newcastle Disease Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Newcastle Disease Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Newcastle Disease Vaccine market is segmented into
Live Vaccines
Killed Vaccines

Segment by Application, the Newcastle Disease Vaccine market is segmented into
Chicken
Duck & Goose
Other

The Newcastle Disease Vaccine market is analysed and market size information is provided by regions (countries). Segment by Application, the Newcastle Disease Vaccine market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Newcastle Disease Vaccine Market Share Analysis
Newcastle Disease Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Newcastle Disease Vaccine business, the date to enter into the Newcastle Disease Vaccine market, Newcastle Disease Vaccine product introduction, recent developments, etc.

The major vendors covered:
Merial
CEVA
QYH Biotech
Ringpu Biology
Yebio
Harbin Veterinary Research Institute
Merck Animal Health
DHN
Zoetis
ChengDu Tecbond
Elanco (Lohmann)
FATRO
CAVAC
Vaksindo

レポート目次

1 Newcastle Disease Vaccine Market Overview
1.1 Newcastle Disease Vaccine Product Scope
1.2 Newcastle Disease Vaccine Segment by Type
1.2.1 Global Newcastle Disease Vaccine Sales by Type (2020-2026)
1.2.2 Live Vaccines
1.2.3 Killed Vaccines
1.3 Newcastle Disease Vaccine Segment by Application
1.3.1 Global Newcastle Disease Vaccine Sales Comparison by Application (2020-2026)
1.3.2 Chicken
1.3.3 Duck & Goose
1.3.4 Other
1.4 Newcastle Disease Vaccine Market Estimates and Forecasts (2015-2026)
1.4.1 Global Newcastle Disease Vaccine Sales Growth Rate (2015-2026)
1.4.2 Global Newcastle Disease Vaccine Revenue and Growth Rate (2015-2026)
1.4.3 Global Newcastle Disease Vaccine Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Newcastle Disease Vaccine Industry Impact
1.5.1 How the Covid-19 is Affecting the Newcastle Disease Vaccine Industry
1.5.1.1 Newcastle Disease Vaccine Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Newcastle Disease Vaccine Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Newcastle Disease Vaccine Players to Combat Covid-19 Impact

2 Newcastle Disease Vaccine Estimate and Forecast by Region
2.1 Global Newcastle Disease Vaccine Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Newcastle Disease Vaccine Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Newcastle Disease Vaccine Sales Market Share by Region (2015-2020)
2.2.2 Global Newcastle Disease Vaccine Revenue Market Share by Region (2015-2020)
2.3 Global Newcastle Disease Vaccine Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Newcastle Disease Vaccine Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Newcastle Disease Vaccine Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Newcastle Disease Vaccine Estimates and Projections (2015-2026)
2.4.2 Europe Newcastle Disease Vaccine Estimates and Projections (2015-2026)
2.4.3 China Newcastle Disease Vaccine Estimates and Projections (2015-2026)
2.4.4 Japan Newcastle Disease Vaccine Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Newcastle Disease Vaccine Estimates and Projections (2015-2026)
2.4.6 India Newcastle Disease Vaccine Estimates and Projections (2015-2026)
3 Global Newcastle Disease Vaccine Competition Landscape by Players
3.1 Global Top Newcastle Disease Vaccine Players by Sales (2015-2020)
3.2 Global Top Newcastle Disease Vaccine Players by Revenue (2015-2020)
3.3 Global Newcastle Disease Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Newcastle Disease Vaccine as of 2019)
3.4 Global Newcastle Disease Vaccine Average Price by Company (2015-2020)
3.5 Manufacturers Newcastle Disease Vaccine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Newcastle Disease Vaccine Players (Opinion Leaders)
4 Global Newcastle Disease Vaccine Market Size by Type
4.1 Global Newcastle Disease Vaccine Historic Market Review by Type (2015-2020)
4.1.1 Global Newcastle Disease Vaccine Sales Market Share by Type (2015-2020)
4.1.2 Global Newcastle Disease Vaccine Revenue Market Share by Type (2015-2020)
4.1.3 Global Newcastle Disease Vaccine Price by Type (2014-2020)
4.2 Global Newcastle Disease Vaccine Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Newcastle Disease Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Newcastle Disease Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Global Newcastle Disease Vaccine Price Forecast by Type (2021-2026)
5 Global Newcastle Disease Vaccine Market Size by Application
5.1 Global Newcastle Disease Vaccine Historic Market Review by Application (2015-2020)
5.1.1 Global Newcastle Disease Vaccine Sales Market Share by Application (2015-2020)
5.1.2 Global Newcastle Disease Vaccine Revenue Market Share by Application (2015-2020)
5.1.3 Global Newcastle Disease Vaccine Price by Application (2015-2020)
5.2 Global Newcastle Disease Vaccine Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Newcastle Disease Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Newcastle Disease Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Newcastle Disease Vaccine Price Forecast by Application (2021-2026)

3 North America Newcastle Disease Vaccine Market Facts & Figures
3.2 North America Newcastle Disease Vaccine Sales Market Share by Company (2015-2020)
3.3 North America Newcastle Disease Vaccine Sales Market Share by Type (2015-2020)
3.4 North America Newcastle Disease Vaccine Sales Market Share by Application (2015-2020)

4 Europe Newcastle Disease Vaccine Market Facts & Figures
4.2 Europe Newcastle Disease Vaccine Sales Market Share by Company (2015-2020)
4.3 Europe Newcastle Disease Vaccine Sales Market Share by Type (2015-2020)
4.4 Europe Newcastle Disease Vaccine Sales Market Share by Application (2015-2020)

5 China Newcastle Disease Vaccine Market Facts & Figures
5.2 China Newcastle Disease Vaccine Sales Market Share by Company (2015-2020)
5.3 China Newcastle Disease Vaccine Sales Market Share by Type (2015-2020)
5.4 China Newcastle Disease Vaccine Sales Market Share by Application (2015-2020)

6 Japan Newcastle Disease Vaccine Market Facts & Figures
6.2 Japan Newcastle Disease Vaccine Sales Market Share by Company (2015-2020)
6.3 Japan Newcastle Disease Vaccine Sales Market Share by Type (2015-2020)
6.4 Japan Newcastle Disease Vaccine Sales Market Share by Application (2015-2020)

7 Southeast Asia Newcastle Disease Vaccine Market Facts & Figures
7.2 Southeast Asia Newcastle Disease Vaccine Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Newcastle Disease Vaccine Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Newcastle Disease Vaccine Sales Market Share by Application (2015-2020)

8 India Newcastle Disease Vaccine Market Facts & Figures
8.2 India Newcastle Disease Vaccine Sales Market Share by Company (2015-2020)
8.3 India Newcastle Disease Vaccine Sales Market Share by Type (2015-2020)
8.4 India Newcastle Disease Vaccine Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Newcastle Disease Vaccine Business
12.1 Merial
12.1.1 Merial Newcastle Disease Vaccine Corporation Information
12.1.2 Merial Newcastle Disease Vaccine Business Overview and Total Revenue
12.1.3 Merial Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Merial Newcastle Disease Vaccine Products Offered
12.1.5 Merial Recent Development
12.2 CEVA
12.2.1 CEVA Newcastle Disease Vaccine Corporation Information
12.2.2 CEVA Newcastle Disease Vaccine Business Overview and Total Revenue
12.2.3 CEVA Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.2.4 CEVA Newcastle Disease Vaccine Products Offered
12.2.5 CEVA Recent Development
12.3 QYH Biotech
12.3.1 QYH Biotech Newcastle Disease Vaccine Corporation Information
12.3.2 QYH Biotech Newcastle Disease Vaccine Business Overview and Total Revenue
12.3.3 QYH Biotech Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.3.4 QYH Biotech Newcastle Disease Vaccine Products Offered
12.3.5 QYH Biotech Recent Development
12.4 Ringpu Biology
12.4.1 Ringpu Biology Newcastle Disease Vaccine Corporation Information
12.4.2 Ringpu Biology Newcastle Disease Vaccine Business Overview and Total Revenue
12.4.3 Ringpu Biology Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Ringpu Biology Newcastle Disease Vaccine Products Offered
12.4.5 Ringpu Biology Recent Development
12.5 Yebio
12.5.1 Yebio Newcastle Disease Vaccine Corporation Information
12.5.2 Yebio Newcastle Disease Vaccine Business Overview and Total Revenue
12.5.3 Yebio Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Yebio Newcastle Disease Vaccine Products Offered
12.5.5 Yebio Recent Development
12.6 Harbin Veterinary Research Institute
12.6.1 Harbin Veterinary Research Institute Newcastle Disease Vaccine Corporation Information
12.6.2 Harbin Veterinary Research Institute Newcastle Disease Vaccine Business Overview and Total Revenue
12.6.3 Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Harbin Veterinary Research Institute Newcastle Disease Vaccine Products Offered
12.6.5 Harbin Veterinary Research Institute Recent Development
12.7 Merck Animal Health
12.7.1 Merck Animal Health Newcastle Disease Vaccine Corporation Information
12.7.2 Merck Animal Health Newcastle Disease Vaccine Business Overview and Total Revenue
12.7.3 Merck Animal Health Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Merck Animal Health Newcastle Disease Vaccine Products Offered
12.7.5 Merck Animal Health Recent Development
12.8 DHN
12.8.1 DHN Newcastle Disease Vaccine Corporation Information
12.8.2 DHN Newcastle Disease Vaccine Business Overview and Total Revenue
12.8.3 DHN Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.8.4 DHN Newcastle Disease Vaccine Products Offered
12.8.5 DHN Recent Development
12.9 Zoetis
12.9.1 Zoetis Newcastle Disease Vaccine Corporation Information
12.9.2 Zoetis Newcastle Disease Vaccine Business Overview and Total Revenue
12.9.3 Zoetis Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Zoetis Newcastle Disease Vaccine Products Offered
12.9.5 Zoetis Recent Development
12.10 ChengDu Tecbond
12.10.1 ChengDu Tecbond Newcastle Disease Vaccine Corporation Information
12.10.2 ChengDu Tecbond Newcastle Disease Vaccine Business Overview and Total Revenue
12.10.3 ChengDu Tecbond Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.10.4 ChengDu Tecbond Newcastle Disease Vaccine Products Offered
12.10.5 ChengDu Tecbond Recent Development
12.11 Elanco (Lohmann)
12.11.1 Elanco (Lohmann) Newcastle Disease Vaccine Corporation Information
12.11.2 Elanco (Lohmann) Newcastle Disease Vaccine Business Overview and Total Revenue
12.11.3 Elanco (Lohmann) Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Elanco (Lohmann) Newcastle Disease Vaccine Products Offered
12.11.5 Elanco (Lohmann) Recent Development
12.12 FATRO
12.12.1 FATRO Newcastle Disease Vaccine Corporation Information
12.12.2 FATRO Newcastle Disease Vaccine Business Overview and Total Revenue
12.12.3 FATRO Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.12.4 FATRO Newcastle Disease Vaccine Products Offered
12.12.5 FATRO Recent Development
12.13 CAVAC
12.13.1 CAVAC Newcastle Disease Vaccine Corporation Information
12.13.2 CAVAC Newcastle Disease Vaccine Business Overview and Total Revenue
12.13.3 CAVAC Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.13.4 CAVAC Newcastle Disease Vaccine Products Offered
12.13.5 CAVAC Recent Development
12.14 Vaksindo
12.14.1 Vaksindo Newcastle Disease Vaccine Corporation Information
12.14.2 Vaksindo Newcastle Disease Vaccine Business Overview and Total Revenue
12.14.3 Vaksindo Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Vaksindo Newcastle Disease Vaccine Products Offered
12.14.5 Vaksindo Recent Development

13 Newcastle Disease Vaccine Manufacturing Cost Analysis
13.1 Newcastle Disease Vaccine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Newcastle Disease Vaccine
13.4 Newcastle Disease Vaccine Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Newcastle Disease Vaccine Distributors List
14.3 Newcastle Disease Vaccine Customers

15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Newcastle Disease Vaccine Sales (M Doses) Growth Rate by Type (2020-2026)
Table 2. Global Newcastle Disease Vaccine Sales (M Doses) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Newcastle Disease Vaccine Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Newcastle Disease Vaccine Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Newcastle Disease Vaccine Players to Combat Covid-19 Impact
Table 8. Global Market Newcastle Disease Vaccine Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Newcastle Disease Vaccine Sales (M Doses) by Region (2015-2020)
Table 10. Global Newcastle Disease Vaccine Sales Market Share by Region (2015-2020)
Table 11. Global Newcastle Disease Vaccine Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Newcastle Disease Vaccine Revenue Share by Region (2015-2020)
Table 13. Global Newcastle Disease Vaccine Sales (M Doses) Forecast by Region (2021-2026)
Table 14. Global Newcastle Disease Vaccine Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Newcastle Disease Vaccine Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Newcastle Disease Vaccine Revenue Share Forecast by Region (2021-2026)
Table 17. Global Newcastle Disease Vaccine (M Doses) of Key Companies (2015-2020)
Table 18. Global Newcastle Disease Vaccine Sales Share by Company (2015-2020)
Table 19. Global Newcastle Disease Vaccine Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Newcastle Disease Vaccine Revenue Share by Company (2015-2020)
Table 21. Global Newcastle Disease Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Newcastle Disease Vaccine as of 2019)
Table 22. Global Newcastle Disease Vaccine Average Price (USD/K Doses) of Key Company (2015-2020)
Table 23. Manufacturers Newcastle Disease Vaccine Manufacturing Sites and Area Served
Table 24. Manufacturers Newcastle Disease Vaccine Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Newcastle Disease Vaccine Players
Table 27. Global Newcastle Disease Vaccine Sales (M Doses) by Type (2015-2020)
Table 28. Global Newcastle Disease Vaccine Sales Share by Type (2015-2020)
Table 29. Global Newcastle Disease Vaccine Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Newcastle Disease Vaccine Price (M Doses) by Type (2015-2020)
Table 31. Global Newcastle Disease Vaccine Sales Share by Type (2021-2026)
Table 32. Global Newcastle Disease Vaccine Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Newcastle Disease Vaccine Revenue Share by Type (2021-2026)
Table 34. Global Newcastle Disease Vaccine Price (M Doses) by Type (2021-2026)
Table 35. Global Newcastle Disease Vaccine Sales (M Doses) by Application (2015-2020)
Table 36. Global Newcastle Disease Vaccine Sales Share by Application (2015-2020)
Table 37. Global Newcastle Disease Vaccine Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Newcastle Disease Vaccine Price (M Doses) by Application (2015-2020)
Table 39. Global Newcastle Disease Vaccine Sales (M Doses) by Application (2021-2026)
Table 40. Global Newcastle Disease Vaccine Sales Share by Application (2021-2026)
Table 41. Global Newcastle Disease Vaccine Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Newcastle Disease Vaccine Revenue Share by Application (2021-2026)
Table 43. Global Newcastle Disease Vaccine Price (M Doses) by Application (2021-2026)
Table 44. United States Newcastle Disease Vaccine Sales (M Doses) by Company (2015-2020)
Table 45. United States Newcastle Disease Vaccine Sales Market Share by Company (2015-2020)
Table 46. United States Newcastle Disease Vaccine Sales (M Doses) by Type (2015-2020)
Table 47. United States Newcastle Disease Vaccine Sales Market Share by Type (2015-2020)
Table 48. United States Newcastle Disease Vaccine Sales (M Doses) by Application (2015-2020)
Table 49. United States Newcastle Disease Vaccine Sales Market Share by Application (2015-2020)
Table 50. Europe Newcastle Disease Vaccine Sales (M Doses) by Company (2015-2020)
Table 51. Europe Newcastle Disease Vaccine Sales Market Share by Company (2015-2020)
Table 52. Europe Newcastle Disease Vaccine Sales (M Doses) by Type (2015-2020)
Table 53. Europe Newcastle Disease Vaccine Sales Market Share by Type (2015-2020)
Table 54. Europe Newcastle Disease Vaccine Sales (M Doses) by Application (2015-2020)
Table 55. Europe Newcastle Disease Vaccine Sales Market Share by Type (2015-2020)
Table 56. China Newcastle Disease Vaccine Sales (M Doses) by Company (2015-2020)
Table 57. China Newcastle Disease Vaccine Sales Market Share by Company (2015-2020)
Table 58. China Newcastle Disease Vaccine Sales (M Doses) by Type (2015-2020)
Table 59. China Newcastle Disease Vaccine Sales Market Share by Type (2015-2020)
Table 60. China Newcastle Disease Vaccine Sales (M Doses) by Application (2015-2020)
Table 61. China Newcastle Disease Vaccine Sales Market Share by Application (2015-2020)
Table 62. Japan Newcastle Disease Vaccine Sales (M Doses) by Company (2015-2020)
Table 63. Japan Newcastle Disease Vaccine Sales Market Share by Company (2015-2020)
Table 64. Japan Newcastle Disease Vaccine Sales (M Doses) by Type (2015-2020)
Table 65. Japan Newcastle Disease Vaccine Sales Market Share by Type (2015-2020)
Table 66. Japan Newcastle Disease Vaccine Sales (M Doses) by Application (2015-2020)
Table 67. Japan Newcastle Disease Vaccine Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Newcastle Disease Vaccine Sales (M Doses) by Company (2015-2020)
Table 69. Southeast Asia Newcastle Disease Vaccine Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Newcastle Disease Vaccine Sales (M Doses) by Type (2015-2020)
Table 71. Southeast Asia Newcastle Disease Vaccine Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Newcastle Disease Vaccine Sales (M Doses) by Type (2015-2020)
Table 73. Southeast Asia Newcastle Disease Vaccine Sales Market Share by Application (2015-2020)
Table 74. India Newcastle Disease Vaccine Sales (M Doses) by Company (2015-2020)
Table 75. India Newcastle Disease Vaccine Sales Market Share by Company (2015-2020)
Table 76. India Newcastle Disease Vaccine Sales (M Doses) by Type (2015-2020)
Table 77. India Newcastle Disease Vaccine Sales Market Share by Type (2015-2020)
Table 78. India Newcastle Disease Vaccine Sales (M Doses) by Application (2015-2020)
Table 79. India Newcastle Disease Vaccine Sales Market Share by Application (2015-2020)
Table 80. Merial Corporation Information
Table 81. Merial Description and Business Overview
Table 82. Merial Newcastle Disease Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 83. Merial Newcastle Disease Vaccine Product
Table 84. Merial Recent Development
Table 85. CEVA Corporation Information
Table 86. CEVA Description and Business Overview
Table 87. CEVA Newcastle Disease Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 88. CEVA Newcastle Disease Vaccine Product
Table 89. CEVA Recent Development
Table 90. QYH Biotech Corporation Information
Table 91. QYH Biotech Description and Business Overview
Table 92. QYH Biotech Newcastle Disease Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 93. QYH Biotech Newcastle Disease Vaccine Product
Table 94. QYH Biotech Recent Development
Table 95. Ringpu Biology Corporation Information
Table 96. Ringpu Biology Description and Business Overview
Table 97. Ringpu Biology Newcastle Disease Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 98. Ringpu Biology Newcastle Disease Vaccine Product
Table 99. Ringpu Biology Recent Development
Table 100. Yebio Corporation Information
Table 101. Yebio Description and Business Overview
Table 102. Yebio Newcastle Disease Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 103. Yebio Newcastle Disease Vaccine Product
Table 104. Yebio Recent Development
Table 105. Harbin Veterinary Research Institute Corporation Information
Table 106. Harbin Veterinary Research Institute Description and Business Overview
Table 107. Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 108. Harbin Veterinary Research Institute Newcastle Disease Vaccine Product
Table 109. Harbin Veterinary Research Institute Recent Development
Table 110. Merck Animal Health Corporation Information
Table 111. Merck Animal Health Description and Business Overview
Table 112. Merck Animal Health Newcastle Disease Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 113. Merck Animal Health Newcastle Disease Vaccine Product
Table 114. Merck Animal Health Recent Development
Table 115. DHN Corporation Information
Table 116. DHN Newcastle Disease Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 117. DHN Description and Business Overview
Table 118. DHN Newcastle Disease Vaccine Product
Table 119. DHN Recent Development
Table 120. Zoetis Corporation Information
Table 121. Zoetis Newcastle Disease Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 122. Zoetis Description and Business Overview
Table 123. Zoetis Newcastle Disease Vaccine Product
Table 124. Zoetis Recent Development
Table 125. ChengDu Tecbond Corporation Information
Table 126. ChengDu Tecbond Description and Business Overview
Table 127. ChengDu Tecbond Newcastle Disease Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 128. ChengDu Tecbond Newcastle Disease Vaccine Product
Table 129. ChengDu Tecbond Recent Development
Table 130. Elanco (Lohmann) Corporation Information
Table 131. Elanco (Lohmann) Description and Business Overview
Table 132. Elanco (Lohmann) Newcastle Disease Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 133. Elanco (Lohmann) Newcastle Disease Vaccine Product
Table 134. Elanco (Lohmann) Recent Development
Table 135. FATRO Corporation Information
Table 136. FATRO Description and Business Overview
Table 137. FATRO Newcastle Disease Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 138. FATRO Newcastle Disease Vaccine Product
Table 139. FATRO Recent Development
Table 140. CAVAC Corporation Information
Table 141. CAVAC Description and Business Overview
Table 142. CAVAC Newcastle Disease Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 143. CAVAC Newcastle Disease Vaccine Product
Table 144. CAVAC Recent Development
Table . Vaksindo Corporation Information
Table . Vaksindo Description and Business Overview
Table . Vaksindo Newcastle Disease Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table . Vaksindo Newcastle Disease Vaccine Product
Table . Vaksindo Recent Development
Table 150. Production Base and Market Concentration Rate of Raw Material
Table 151. Key Suppliers of Raw Materials
Table 152. Newcastle Disease Vaccine Distributors List
Table 153. Newcastle Disease Vaccine Customers List
Table 154. Market Key Trends
Table 155. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 156. Key Challenges
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Newcastle Disease Vaccine Product Picture
Figure 2. Global Newcastle Disease Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Newcastle Disease Vaccine Market Share by Application in 2020 & 2026
Figure 6. Chicken Examples
Figure 7. Duck & Goose Examples
Figure 8. Other Examples
Figure 9. Global Newcastle Disease Vaccine Sales (M Doses) Growth Rate (2015-2026)
Figure 10. Global Newcastle Disease Vaccine Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Newcastle Disease Vaccine Price Trends Growth Rate (2015-2026) (USD/K Doses)
Figure 12. Global Newcastle Disease Vaccine Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Newcastle Disease Vaccine Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Newcastle Disease Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Newcastle Disease Vaccine Sales (M Doses) Growth Rate (2015-2026)
Figure 16. Europe Newcastle Disease Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Newcastle Disease Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Newcastle Disease Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Newcastle Disease Vaccine Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Newcastle Disease Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Newcastle Disease Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Newcastle Disease Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Newcastle Disease Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Newcastle Disease Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Newcastle Disease Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Newcastle Disease Vaccine Players Market Share by Revenue in Newcastle Disease Vaccine 2015 & 2019
Figure 27. Newcastle Disease Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Newcastle Disease Vaccine Revenue Share by Type (2015-2020)
Figure 29. Global Newcastle Disease Vaccine Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Newcastle Disease Vaccine Revenue Share by Application (2015-2020)
Figure 31. Global Newcastle Disease Vaccine Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Newcastle Disease Vaccine Sales Market Share by Type in 2019
Figure 33. United States Newcastle Disease Vaccine Sales Market Share by Type in 2019
Figure 34. Europe Newcastle Disease Vaccine Sales Market Share by Company in 2019
Figure 35. Europe Newcastle Disease Vaccine Sales Market Share by Type in 2019
Figure 36. Europe Newcastle Disease Vaccine Sales Market Share by Application in 2019
Figure 37. China Newcastle Disease Vaccine Sales Market Share by Company in 2019
Figure 38. China Newcastle Disease Vaccine Sales Market Share by Type in 2019
Figure 39. China Newcastle Disease Vaccine Sales Market Share by Application in 2019
Figure 40. Japan Newcastle Disease Vaccine Sales Market Share by Company in 2019
Figure 41. Japan Newcastle Disease Vaccine Sales Market Share by Type in 2019
Figure 42. Japan Newcastle Disease Vaccine Sales Market Share by Application in 2019
Figure 43. Southeast Asia Newcastle Disease Vaccine Sales Market Share by Company in 2019
Figure 44. Southeast Asia Newcastle Disease Vaccine Sales Market Share by Type in 2019
Figure 45. Southeast Asia Newcastle Disease Vaccine Sales Market Share by Application in 2019
Figure 46. India Newcastle Disease Vaccine Sales Market Share by Company in 2019
Figure 47. India Newcastle Disease Vaccine Sales Market Share by Type in 2019
Figure 48. India Newcastle Disease Vaccine Sales Market Share by Application in 2019
Figure 49. Merial Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. CEVA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. QYH Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Ringpu Biology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Yebio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Harbin Veterinary Research Institute Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Merck Animal Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. DHN Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Zoetis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. ChengDu Tecbond Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Elanco (Lohmann) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. FATRO Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. CAVAC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Vaksindo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Key Raw Materials Price Trend
Figure 64. Manufacturing Cost Structure of Newcastle Disease Vaccine
Figure 65. Manufacturing Process Analysis of Newcastle Disease Vaccine
Figure 66. Newcastle Disease Vaccine Industrial Chain Analysis
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
Figure 69. Porter's Five Forces Analysis
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed